Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S.

Heartflow is once again looking for a path to go public, with a filing for a Nasdaq IPO. | The former Fierce Medtech Fierce ...

Heartflow has filed for an initial public offering. The company recorded sales of $125.8 million and a net loss of $96.4 million last year, according to a filing with the Securities and Exchange ...

The U.S. IPO market is witnessing a renewed vigor as investors return following months of sluggish activity triggered by ...

Such well-funded companies are ripe targets for IPO. Heartflow has been venture-backed since 2009, ramped up the amounts it has raised consistently – with a $100+ million round that wrapped up ...

The firm found that companies tended to IPO at an age of about 10 years and after raising roughly $200 million. ... HeartFlow has a $1.56 billion valuation, according to PitchBook.

Heartflow Holding Inc. is aiming to bring its noninvasive, artificial intelligence (AI)-based test for coronary heart disease to more doctors and patients via a merger with Longview Acquisition Corp.

Heartflow Holding Inc (NYSE: HFLO) aims to bring its noninvasive, artificial intelligence (AI)-based test for coronary heart disease to more doctors and patients via a SPAC merger with Longview ...

MOUNTAIN VIEW, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the global leader in AI technology for coronary artery disease (CAD) management, today introduced its new.

MOUNTAIN VIEW, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced additional investments in the company of ...

HeartFlow helps diagnose heart disease without invasive procedures and has been used on 500,000 patients. Taylor has developed one of the few examples of AI that has received FDA approval and ...